Elisabeth S. Bergen - Publications

Cause-Specific Mortality in Gastroesophageal Cancer: A 30-Year Real-World Analysis from the Vienna Gastroesophageal Cancer Database.

Journal: Clinical epidemiology

Published: April 27, 2026

Therapeutic management of resectable mismatch-repair deficient/microsatellite instability-high gastroesophageal adenocarcinoma: a real-world analysis from Austria.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: April 06, 2026

Response to letter Re: Impact of concomitant medication on recurrence, survival and tolerability of chemotherapy in early colon cancer patients - A post-hoc analysis of the PETACC 8 trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 03, 2025

Lack of association between prior or concurrent malignancies and overall survival in gastroesophageal cancer: evidence from a large European single-center cohort.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 19, 2025

Trastuzumab in Addition to Chemotherapy in Patients With Metastatic Human Epidermal Growth Factor Receptor 2-Positive Gastroesophageal Cancer-A Real-World Experience.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: April 29, 2025

Circulating tumor DNA driving anti-EGFR rechallenge therapy in metastatic colorectal cancer: the RASINTRO prospective multicenter study.

Journal: Journal of the National Cancer Institute

Published: March 02, 2025

Impact of concomitant medication on recurrence, survival and tolerability of chemotherapy in early colon cancer patients - A post-hoc analysis of the PETACC 8 trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 09, 2025

Ascites of patients with solid tumors shows distinct inflammatory patterns.

Journal: Cancer communications (London, England)

Published: December 11, 2024

Correction to: Association of family history with patient characteristics and prognosis in a large European gastroesophageal cancer cohort.

Journal: Wiener klinische Wochenschrift

Published: October 18, 2024

Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastases.

Journal: Neuro-oncology

Published: July 04, 2024

Association of family history with patient characteristics and prognosis in a large European gastroesophageal cancer cohort.

Journal: Wiener klinische Wochenschrift

Published: June 04, 2024

Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study.

Journal: ESMO open

Published: March 09, 2024